logo
Select company
Select metric
2Current Ratio
VS
Market
54
Sector
32
Industry
22
History
5
$ 27.8Close
$ 13.49 - $ 27.89 52-Week Range
Ticker Information

Ticker

TVTX

Company Name

TRAVERE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

TRAVERE THERAPEUTICS INC - Current Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

TVTX - Current Ratio Historical data
DateCurrent AssetsCurrent RatioCurrent Liabilities
6/30/2025$ 379.57M2$ 189.54M
3/31/2025$ 374.17M2.05$ 182.46M
12/31/2024$ 416.7M2.08$ 200.75M
9/30/2024$ 324.74M1.71$ 190.04M
6/30/2024$ 368.98M3.04$ 121.27M
3/31/2024$ 481.08M2.78$ 173.23M
12/31/2023$ 616.77M3.47$ 177.91M
9/30/2023$ 686.23M4.92$ 139.43M
6/30/2023$ 542.05M3.99$ 135.71M
3/31/2023$ 604.9M4.63$ 130.65M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • TRAVERE THERAPEUTICS INC's latest trailing twelve months (TTM) Current Ratio stands at 6.6.
  • Over the past 5 years, TRAVERE THERAPEUTICS INC's average Current Ratio has been 4.07.
  • The median Current Ratio for TRAVERE THERAPEUTICS INC during this period was 4.26
  • TRAVERE THERAPEUTICS INC reached its highest Current Ratio over the past 5 years at 6.65.
  • The lowest Current Ratio recorded by TRAVERE THERAPEUTICS INC in the same timeframe 1.71

TRAVERE THERAPEUTICS INC's Current Ratio vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Current Ratio Benchmarks
CompanyCurrent Ratio
IMCR : IMMUNOCORE HOLDINGS PLC 5.89TARS : TARSUS PHARMACEUTICALS INC 5.26INVA : INNOVIVA INC 2.64VCEL : VERICEL CORP 4.97MNKD : MANNKIND CORP 2.5ARQT : ARCUTIS BIOTHERAPEUTICS INC 3.2AUPH : AURINIA PHARMACEUTICALS INC 5.23MDXG : MIMEDX GROUP INC 4.39ARDX : ARDELYX INC 4.3ADPT : ADAPTIVE BIOTECHNOLOGIES CORP 2.84

Definition of Current Ratio

[Calculation] The current ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations due within one year. Calculated by dividing current assets [AssetsC] by current liabilities [LiabilitiesC].
AssetsC / LiabilitesC
(=) Current Ratio
Current Ratio for TRAVERE THERAPEUTICS INC is calculated as follows: AssetsC [ $ 497.68M ] / LiabilitesC [ $ 75.43M ]
(=) Current Ratio [ 6.6 ]

TVTX - Current Ratio, Last 5 years

1.71

Minimum

Sep 30, 2024

6.65

Maximum

Mar 31, 2021

4.07

Average

4.26

Median

Current Ratio Benchmark Analysis

The chart above depicts the distribution of Current Ratio for companies in the Total Stock Market. The average Current Ratio of the companies is 2.02 with a standard deviation of 1.44.
The following table provides additional summary stats:
Current Ratio in the Market:
filtered constituents3.2K
min0
max6.79
average2.02
median1.62
std1.44